Porcilis® Ery + Parvo + Lepto is a multivalent vaccine designed to provide protection against three major groups of pathogens that affect reproductive health in sows and replacement gilts, helping maintain reproductive performance and reduce economic losses in pig production.
Porcilis® Ery + Parvo + Lepto is a multivalent vaccine designed to provide protection against three major groups of pathogens that affect reproductive health in sows and replacement gilts, helping maintain reproductive performance and reduce economic losses in pig production.
Erysipelothrix rhusiopathiae: Serotypes 1 and 2.
Porcine parvovirus.
Leptospira: Serovars Canicola, Icterohaemorrhagiae, Grippotyphosa, and Pomona.
Prevention of swine erysipelas caused by Erysipelothrix rhusiopathiae.
Prevention of porcine parvovirus infection, which may cause reproductive disorders, including abortion and stillbirths.
Prevention of leptospirosis, an infectious disease that can adversely affect reproductive health in pigs.
Supports reproductive health protection against the pathogens included in the vaccine.
Helps reduce the risk of abortion and stillbirths.
Supports improved conception rates and the number of piglets weaned.
Helps reduce treatment costs and sow culling associated with reproductive problems.
Dosage: 2 ml per animal.
Route of administration: Intramuscular injection.
Duration of protection: Up to 6 months, subject to the manufacturer's approved product information.
10-dose vial.
